- Report
- October 2023
- 140 Pages
North America
From €4222EUR$4,400USD£3,636GBP
- Report
- November 2023
- 80 Pages
Germany
From €3358EUR$3,500USD£2,892GBP
- Report
- August 2022
- 120 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Book
- June 2021
- 866 Pages
- Book
- December 2018
North America
Proteinuria is a condition in which an abnormal amount of protein is present in the urine. It is a common symptom of kidney disease and can be caused by a variety of conditions, including diabetes, hypertension, and lupus. Proteinuria is often monitored by urologists and nephrologists, who specialize in the diagnosis and treatment of kidney diseases. Treatment for proteinuria typically involves lifestyle changes, such as reducing salt intake and increasing physical activity, as well as medications to reduce protein levels in the urine. In some cases, surgery may be necessary to repair damaged kidneys.
The proteinuria market is a growing segment of the urology and nephrology industry, with a range of products and services available to diagnose and treat the condition. Companies in the market include Abbott Laboratories, AstraZeneca, B. Braun Melsungen AG, Baxter International, Fresenius Medical Care, and Merck & Co. Show Less Read more